Life-Saving Lung Checks Now Available at Eric Moore Partnership

Posted on:

At Eric Moore Partnership, we are excited to announce that we are now offering life-saving lung checks to our patients. These checks are part of a significant initiative being rolled out across Warrington to detect lung problems, including cancer, at the earliest stages when treatment is most effective.

The Targeted Lung Health Check program, which has already saved lives across Cheshire and Merseyside, is now available to patients at our practice. Over the next few months, patients aged 55 to 74 who currently smoke or have smoked in the past will be invited to participate in this program. This initiative is the largest of its kind in the NHS, aiming to improve early lung cancer diagnosis on a national scale.

Lung cancer is the UK’s biggest cancer killer, claiming more lives than breast, prostate, and pancreatic cancers combined. However, early detection through these simple lung checks can significantly improve survival rates, with 85% of cancers found at an early stage being more treatable.

The program works by first inviting eligible patients to a telephone consultation with a lung health nurse. Those at higher risk will then be offered a low-dose CT scan in a mobile unit, which is far more effective at detecting lung cancer than standard X-rays. The checks are painless, quick, and free of charge.

Owen McGrath, one of the program’s beneficiaries, shared his experience: “I’m just so glad I went for the check. They found something during the scan, and after further tests, they confirmed it was cancer. Thanks to early detection and treatment, I’m still here today.”

We strongly encourage all eligible patients to attend their appointment, even if they feel well. Early detection is key, and these checks could save your life.

For more information on the Targeted Lung Health Check program, visit the NHS Lung Health Check website.

To read more about the initiative, check out the full articles on Warrington Worldwide and Warrington Guardian.